Frisch Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-425
Closed -$215K 132
2023
Q3
$215K Sell
425
-33
-7% -$17.6K 0.09% 108
2023
Q2
$239K Sell
458
-267
-37% -$144K 0.11% 96
2023
Q1
$418K Buy
+725
New +$409K 0.16% 78
2022
Q2
Sell
-556
Closed -$329K 140
2022
Q1
$329K Sell
556
-90
-14% -$51.7K 0.11% 105
2021
Q4
$431K Buy
646
+215
+50% +$134K 0.14% 92
2021
Q3
$246K Hold
431
0.08% 132
2021
Q2
$217K Sell
431
-75
-15% -$35.4K 0.07% 136
2021
Q1
$231K Buy
506
+50
+11% +$23.9K 0.08% 134
2020
Q4
$212K Buy
+456
New +$214K 0.08% 126

Other funds holding TMO

Frisch Financial Group's TMO Position: Q4 2023 in Review

Frisch Financial Group sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 425 shares — an estimated $215K sold.

Frisch Financial Group first reported a position in TMO in Q4 2020 and held it in 9 quarters. The position peaked at $431K in Q4 2021. 2,491 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Frisch Financial Group reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • Frisch Financial Group sold 425 Thermo Fisher Scientific shares in Q4 2023, an estimated $215K.
  • Frisch Financial Group first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 9 quarters.
  • Frisch Financial Group's Thermo Fisher Scientific position peaked at $431K in Q4 2021.
  • 2,491 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Frisch Financial Group's 13F filing for Q4 2023, filed 12 Feb 2024.